title: Cesarean delivery versus vaginal delivery: impact on survival and morbidity for the breech fetus at the threshold of viability.
abstract: OBJECTIVE
  To determine if cesarean delivery is associated with improved survival and morbidity in the breech fetus at the threshold of viability.
  
  
  METHODS
  The Missouri maternally linked cohort data files covering the period 1989 through 2005 were utilized for analysis. All pregnancies with singleton fetuses in the breech presentation delivered between 23(0) and 24(6) weeks gestation and birth weights between 400 and 750 g were included. Logistic regression was used to compare cesarean to vaginal delivery after controlling for maternal demographics and pregnancy complications.
  
  
  RESULTS
  A total of 325 breech singletons were analyzed; cesarean deliveries accounted for 46.1% (150) and vaginal deliveries accounted for 53.9% (175). Cesarean delivery was associated with a survival benefit across all birth weights. Morbidity was higher in cesarean compared to vaginal delivery.
  
  
  CONCLUSIONS
  Although cesarean delivery appears to be associated with an increase in survival at the threshold of viability for the breech fetus, there is a concomitant increase in morbidity. Any benefit that cesarean delivery conveys on survival at the threshold of viability should be weighed against the increased maternal morbidity and high overall neonatal morbidity.
authors.affiliation: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL 33606, USA. adeutsch@hsc.usf.edu
authors.forename: Aaron
authors.initials: A
authors.lastname: Deutsch
authors.forename: Hamisu M
authors.initials: HM
authors.lastname: Salihu
authors.forename: O'Neill
authors.initials: O
authors.lastname: Lynch
authors.forename: Phillip J
authors.initials: PJ
authors.lastname: Marty
authors.forename: Victoria
authors.initials: V
authors.lastname: Belogolovkin
mesh_terms: D000328:Adult; D001946:Breech Presentation; D002585:Cesarean Section / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D008923:Missouri / Q000453:epidemiology; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D047928:Premature Birth / Q000401:mortality*; D012189:Retrospective Studies